Prospective, Multicenter Study Investigating Efficacy and Safety of Oral Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism in Korean Patients With Cancers
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 06 Jan 2017 Status changed from active, no longer recruiting to completed.
- 21 Jun 2016 Planned End Date changed from 1 Feb 2017 to 1 Dec 2016.
- 21 Jun 2016 Status changed from recruiting to active, no longer recruiting.